Corbus Pharmaceuticals
(NASDAQ) CRBP
Corbus Pharmaceuticals Financials at a Glance
Market Cap
$185.88M
Revenue (TTM)
$0.00
Net Income (TTM)
$78.54M
EPS (TTM)
$-5.98
P/E Ratio
-1.75
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$10.18
Volume
21,041
Open
$10.63
Price
$10.18
Volume
21,041
Open
$10.63
Previous Close
$10.18
Daily Range
$9.96 - $10.67
52-Week Range
$6.10 - $20.56
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$10.18
Volume
21,041
Open
$10.63
Previous Close
$10.18
Daily Range
$9.96 - $10.67
52-Week Range
$6.10 - $20.56
CRBP News
3 Stocks Robinhood Investors Love
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Corbus Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
36
CEO
Yuval Cohen, PhD
Website
www.corbuspharma.comHeadquarters
Norwood, MA 02062, US
CRBP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-54%
Return on Capital
-58%
Return on Assets
-47%
Earnings Yield
-57.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$185.88M
Shares Outstanding
17.74M
Volume
21.04K
Short Interest
0.00%
Avg. Volume
207.40K
Financials (TTM)
Gross Profit
$233.00K
Operating Income
$85.31M
EBITDA
$85.08M
Operating Cash Flow
$64.49M
Capital Expenditure
$7.00K
Free Cash Flow
$64.50M
Cash & ST Invst.
$163.94M
Total Debt
$1.63M
Corbus Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$49.00K
+66.4%
Gross Margin
0.00%
N/A
Market Cap
$185.88M
N/A
Market Cap/Employee
$6.64M
N/A
Employees
28
N/A
Net Income
$20.55M
-115.7%
EBITDA
$59.48M
+733.9%
Quarterly Fundamentals
Net Cash
$162.31M
+11.3%
Accounts Receivable
$1.50M
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$1.63M
+1.7%
Return on Assets
-46.69%
N/A
Return on Invested Capital
-57.84%
N/A
Free Cash Flow
$15.93M
-45.6%
Operating Cash Flow
$15.92M
-45.5%